Rhinitis/rhinorrhea (intranasal products):
Indications for: Mometasone Nasal Spray
Treatment of seasonal and perennial allergic rhinitis symptoms in patients ≥2yrs of age. Prophylaxis of nasal symptoms of seasonal allergic rhinitis symptoms in patients ≥12yrs of age. Nasal polyps.
Allergic rhinitis: ≥12yrs: 2 sprays in each nostril once daily; prophylaxis: begin 2–4 weeks prior to anticipated start of pollen season. Nasal polyps: ≥18yrs: 2 sprays in each nostril 1–2 times daily.
Allergic rhinitis: <2yrs: not established. 2–11yrs: 1 spray in each nostril once daily. Nasal polyps: <18yrs: not established.
Mometasone Nasal Spray Warnings/Precautions:
Maintain regular regimen. Immunosuppression. Respiratory tract tuberculosis. Infections (eg, ocular herpes simplex). If exposed to measles or chickenpox, consider anti-infective prophylactic therapy. Recent nasal septum ulcers, nasal surgery, or nasal trauma; may impair wound healing. Monitor for growth suppression in children. Monitor for hypercorticism and adrenal suppression (if occur discontinue gradually), and candida infection or other nasal mucosal changes. Glaucoma and/or cataracts. Discontinue if nasopharyngeal candida infection or hypersensitivity reactions occurs. Avoid eyes. Hepatic impairment. Pregnancy. Nursing mothers.
Mometasone Nasal Spray Classification:
Mometasone Nasal Spray Interactions:
Caution when concomitant ketoconazole (long-term) and other strong CYP3A4 inhibitors (eg, ritonavir, cobicistat-containing products, atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, saquinavir, telithromycin); monitor.
Headache, viral infection, pharyngitis, epistaxis, cough, upper respiratory tract infection, dysmenorrhea, musculoskeletal pain, sinusitis; nasal ulcers.
Formerly known under the brand name Nasonex.